Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
AIDS (London, England)|December 4, 2020
Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disordersRamya Ramaswami, Kathryn Lurain, Vickie Ann Marshall, et al.Plos One|February 11, 2020
Expression of the muscle-associated gene MYF6 in hairy cell leukemiaEvgeny Arons, Hong Zhou, Mark Sokolsky, et al.Leukemia & Lymphoma|January 15, 2013
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical studyBenjamin M Cherry, Neha Korde, Mary Kwok, et al.Blood|September 5, 2015
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinibClare Sun, Xin Tian, Yuh Shan Lee, et al.Blood Advances|October 4, 2021
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variantDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.Leukemia|March 8, 2019
Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Richard Sposto, Nirali N Shah, et al.Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.Leukemia|September 30, 2018
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Richard Sposto, Nirali N Shah, et al.Blood|October 20, 2010
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiationPatricia Pérez-Galán, Helena Mora-Jensen, Marc A Weniger, et al.The Oncologist|February 8, 2021
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple MyelomaDickran Kazandjian, Alexander Dew, Elizabeth Hill, et al.Pageof 3